OKYO Pharma Ltd (OKYO) AI Dilution Summary

OKYO is funding itself from cash on hand and an at-the-market program. Estimated cash was $20,594,268 as of 2026-03-31, the last balance-sheet date, against estimated monthly burn of $494,658, and the active ATM with Leerink Partners LLC is authorised to $50,000,000. Dilution here is driven primarily by F-3 shelf registration 333-293145, registered to $200,000,000 with $22,059,511 used to date and remaining capacity not determined in the filings reviewed; it expires 2029-02-10.